- Release Date: 11/04/19 09:27
- Summary: Immuron Aims to Secure FDA Approval for IMM-124E
- Price Sensitive: Yes
- Download Document 887.69KB
- Forums
- ASX - By Stock
- IMC
- Ann: Immuron Aims to Secure FDA Approval for IMM-124E
IMC
immuron limited
Add to My Watchlist
1.56%
!
6.3¢

Ann: Immuron Aims to Secure FDA Approval for IMM-124E
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.3¢ |
Change
-0.001(1.56%) |
Mkt cap ! $14.97M |
Open | High | Low | Value | Volume |
6.3¢ | 6.3¢ | 6.3¢ | $453 | 7.185K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 82811 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.8¢ | 70168 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 82811 | 0.062 |
2 | 208360 | 0.061 |
1 | 17858 | 0.060 |
1 | 20000 | 0.058 |
2 | 90000 | 0.057 |
Price($) | Vol. | No. |
---|---|---|
0.068 | 70168 | 1 |
0.069 | 60163 | 2 |
0.070 | 4000 | 1 |
0.076 | 31679 | 1 |
0.077 | 11127 | 1 |
Last trade - 10.18am 07/07/2025 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online